The Genus Walsura: A Rich Resource of Bioactive Limonoids, Triterpenoids, and Other Types of Compounds

Medicinal plants of the genus Walsura (family Meliaceae) are native to tropical zones of a number of Asian countries, and have been used in systems of folk medicine. Several original research articles on Walsura species are available, but an overview highlighting the phytochemical and biological aspects of the compounds isolated to date is so far absent. Since the 1970s, phytochemical investigations on the genus Walsura have been undertaken, and more than 220 compounds from ten species have been identified. Natural products from Walsura species that have received the most attention are limonoids (114 compounds) and triterpenoids (72 compounds). Walsura limonoids have been characterized structurally as having diverse skeletons and more than 100 such compounds are new to the literature, while dammaranes, tirucallanes, and apotirucallanes are the main triterpenoid types from this genus. Other Walsura constituents comprise sesquiterpenoids, flavonoids, sterols, lignans, xanthones, and anthraquinones. Walsura species constituents have also been studied in natural product drug discovery screening programs. Many in vitro biological and some in vivo pharmacological investigations have been carried out on Walsura species isolated compounds. Walsura components display properties such as cancer cell cytotoxicity, antimicrobial, antidiabetes, anti-inflammatory, antioxidant, antifeedant, antifertility, ichthyotoxic, and neuroprotection activities.

Natural Compounds in Sex Hormone-Dependent Cancers: The Role of Triterpenes as Therapeutic Agents

Sex hormone-dependent cancers currently contribute to the high number of cancer-related deaths worldwide. The study and elucidation of the molecular mechanisms underlying the progression of these tumors was a double-edged sword, leading to the expansion and development of new treatment options, with the cost of triggering more aggressive, therapy resistant relapses. The interaction of androgen, estrogen and progesterone hormones with specific receptors (AR, ER, PR) has emerged as a key player in the development and progression of breast, ovarian, prostate and endometrium cancers. Sex hormone-dependent cancers share a common and rather unique carcinogenesis mechanism involving the active role of endogenous and exogenous sex hormones to maintain high mitotic rates and increased cell proliferation thus increasing the probability of aberrant gene occurrence and accumulation highly correlated with abnormal cell division and the occurrence of malignant phenotypes. Cancer related hormone therapy has evolved, currently being associated with the blockade of other signaling pathways often associated with carcinogenesis and tumor progression in cancers, with promising results. However, despite the established developments, there are still several shortcomings to be addressed. Triterpenes are natural occurring secondary metabolites biosynthesized by various pathways starting from squalene cyclization. Due to their versatile therapeutic potential, including the extensively researched antiproliferative effect, these compounds are most definitely a cornerstone in the research and development of new natural/semisynthetic anticancer therapies. The present work thoroughly describes the ongoing research related to the antitumor activity of triterpenes in sex hormone-dependent cancers. Also, the current review highlights both the biological activity of various triterpenoid compounds and their featured mechanisms of action correlated with important chemical structural features.